305 related articles for article (PubMed ID: 37670258)
1. The emerging roles of SUMOylation in pulmonary diseases.
Zheng X; Wang L; Zhang Z; Tang H
Mol Med; 2023 Sep; 29(1):119. PubMed ID: 37670258
[TBL] [Abstract][Full Text] [Related]
2. Sumoylation of CCAAT-enhancer-binding protein α inhibits lung differentiation in Bronchopulmonary Dysplasia model rats.
Zhu Y; Chen X; Mi L; Wang Q; Zhu H; Ju H; Lu H
J Cell Mol Med; 2020 Jun; 24(12):7067-7071. PubMed ID: 32363643
[TBL] [Abstract][Full Text] [Related]
3. Endothelial FIS1 DeSUMOylation Protects Against Hypoxic Pulmonary Hypertension.
Zhou X; Jiang Y; Wang Y; Fan L; Zhu Y; Chen Y; Wang Y; Zhu Y; Wang H; Pan Z; Li Z; Zhu X; Ren R; Ge Z; Lai D; Lai EY; Chen T; Wang K; Liang P; Qin L; Liu C; Qiu C; Simons M; Yu L
Circ Res; 2023 Sep; 133(6):508-531. PubMed ID: 37589160
[TBL] [Abstract][Full Text] [Related]
4. Mapping the SUMOylated landscape.
Eifler K; Vertegaal AC
FEBS J; 2015 Oct; 282(19):3669-80. PubMed ID: 26185901
[TBL] [Abstract][Full Text] [Related]
5. SUMOylation-Mediated Regulation of Cell Cycle Progression and Cancer.
Eifler K; Vertegaal ACO
Trends Biochem Sci; 2015 Dec; 40(12):779-793. PubMed ID: 26601932
[TBL] [Abstract][Full Text] [Related]
6. SUMOylation targeting mitophagy in cardiovascular diseases.
Xiao H; Zhou H; Zeng G; Mao Z; Zeng J; Gao A
J Mol Med (Berl); 2022 Nov; 100(11):1511-1538. PubMed ID: 36163375
[TBL] [Abstract][Full Text] [Related]
7. SUMOylation as a Therapeutic Target for Myocardial Infarction.
Zhao W; Zhang X; Rong J
Front Cardiovasc Med; 2021; 8():701583. PubMed ID: 34395563
[TBL] [Abstract][Full Text] [Related]
8. Protein SUMOylation modification and its associations with disease.
Yang Y; He Y; Wang X; Liang Z; He G; Zhang P; Zhu H; Xu N; Liang S
Open Biol; 2017 Oct; 7(10):. PubMed ID: 29021212
[TBL] [Abstract][Full Text] [Related]
9. The post-translational modification, SUMOylation, and cancer (Review).
Han ZJ; Feng YH; Gu BH; Li YM; Chen H
Int J Oncol; 2018 Apr; 52(4):1081-1094. PubMed ID: 29484374
[TBL] [Abstract][Full Text] [Related]
10. The Ubiquitin-Like SUMO System and Heart Function: From Development to Disease.
Mendler L; Braun T; Müller S
Circ Res; 2016 Jan; 118(1):132-44. PubMed ID: 26837744
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia Triggers SENP1 (Sentrin-Specific Protease 1) Modulation of KLF15 (Kruppel-Like Factor 15) and Transcriptional Regulation of Arg2 (Arginase 2) in Pulmonary Endothelium.
Pandey D; Nomura Y; Rossberg MC; Hori D; Bhatta A; Keceli G; Leucker T; Santhanam L; Shimoda LA; Berkowitz D; Romer L
Arterioscler Thromb Vasc Biol; 2018 Apr; 38(4):913-926. PubMed ID: 29472234
[TBL] [Abstract][Full Text] [Related]
12. c-Myc is targeted to the proteasome for degradation in a SUMOylation-dependent manner, regulated by PIAS1, SENP7 and RNF4.
González-Prieto R; Cuijpers SA; Kumar R; Hendriks IA; Vertegaal AC
Cell Cycle; 2015; 14(12):1859-72. PubMed ID: 25895136
[TBL] [Abstract][Full Text] [Related]
13. Emerging roles of SUMO modification in arthritis.
Yan D; Davis FJ; Sharrocks AD; Im HJ
Gene; 2010 Oct; 466(1-2):1-15. PubMed ID: 20627123
[TBL] [Abstract][Full Text] [Related]
14. The Role of Sumoylation in the Response to Hypoxia: An Overview.
Filippopoulou C; Simos G; Chachami G
Cells; 2020 Oct; 9(11):. PubMed ID: 33114748
[TBL] [Abstract][Full Text] [Related]
15. E2-mediated small ubiquitin-like modifier (SUMO) modification of thymine DNA glycosylase is efficient but not selective for the enzyme-product complex.
Coey CT; Fitzgerald ME; Maiti A; Reiter KH; Guzzo CM; Matunis MJ; Drohat AC
J Biol Chem; 2014 May; 289(22):15810-9. PubMed ID: 24753249
[TBL] [Abstract][Full Text] [Related]
16. SUMO Modification Stabilizes Dengue Virus Nonstructural Protein 5 To Support Virus Replication.
Su CI; Tseng CH; Yu CY; Lai MMC
J Virol; 2016 May; 90(9):4308-4319. PubMed ID: 26889037
[TBL] [Abstract][Full Text] [Related]
17. SUMOylation homeostasis in tumorigenesis.
Xie M; Yu J; Ge S; Huang J; Fan X
Cancer Lett; 2020 Jan; 469():301-309. PubMed ID: 31705931
[TBL] [Abstract][Full Text] [Related]
18. Small-Molecule Inhibitors Targeting Protein SUMOylation as Novel Anticancer Compounds.
Yang Y; Xia Z; Wang X; Zhao X; Sheng Z; Ye Y; He G; Zhou L; Zhu H; Xu N; Liang S
Mol Pharmacol; 2018 Aug; 94(2):885-894. PubMed ID: 29784649
[TBL] [Abstract][Full Text] [Related]
19. SUMOylation pathway in Trypanosoma cruzi: functional characterization and proteomic analysis of target proteins.
Bayona JC; Nakayasu ES; Laverrière M; Aguilar C; Sobreira TJ; Choi H; Nesvizhskii AI; Almeida IC; Cazzulo JJ; Alvarez VE
Mol Cell Proteomics; 2011 Dec; 10(12):M110.007369. PubMed ID: 21832256
[TBL] [Abstract][Full Text] [Related]
20. Oligonucleotide Therapy for Obstructive and Restrictive Respiratory Diseases.
Liao W; Dong J; Peh HY; Tan LH; Lim KS; Li L; Wong WF
Molecules; 2017 Jan; 22(1):. PubMed ID: 28106744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
